Literature DB >> 19954694

The natural progression of kidney injury in young type 1 diabetic patients.

Julia M Steinke1.   

Abstract

Diabetes is the most common cause of end-stage renal disease in industrialized countries. This article describes the structural changes in early diabetic nephropathy and the relationship with renal functional parameters, blood pressure, and albumin excretion. The detrimental influence of sustained hyperglycemia and/or glycemic fluctuations on renal structural change has been well documented. Tight glycemic control is paramount to preventing the development, and even the regression, of renal lesions. As much of the renal injury from diabetes occurs in clinical silence before symptoms or laboratory findings of renal injury are evident, finding early markers of risk is imperative so that nephropathy can be prevented. Currently, the only clinical surrogate marker of diabetic renal injury available is microalbuminuria. However, given the reports of regression of microalbuminuria back to normoalbuminuria, the reliability of this tool as an indicator of risk has been questioned. The need for alternative, noninvasive surrogate markers is described in this report.

Entities:  

Mesh:

Year:  2009        PMID: 19954694     DOI: 10.1007/s11892-009-0077-7

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  77 in total

1.  Standards of medical care for patients with diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

2.  The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

Authors:  H H Parving; H Lehnert; J Bröchner-Mortensen; R Gomis; S Andersen; P Arner
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

3.  Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy.

Authors:  John M Lachin; Saul Genuth; Patricia Cleary; Matthew D Davis; David M Nathan
Journal:  N Engl J Med       Date:  2000-02-10       Impact factor: 91.245

4.  Ambulatory blood pressure and heart rate in relation to kidney structure and metabolic control in adolescents with Type I diabetes.

Authors:  T B Torbjörnsdotter; G A Jaremko; U B Berg
Journal:  Diabetologia       Date:  2001-07       Impact factor: 10.122

5.  Sequential renal biopsies in insulin-dependent diabetic patients: structural factors associated with clinical progression.

Authors:  P Fioretto; M W Steffes; D E Sutherland; M Mauer
Journal:  Kidney Int       Date:  1995-12       Impact factor: 10.612

6.  Predicting diabetic nephropathy in insulin-dependent patients.

Authors:  C E Mogensen; C K Christensen
Journal:  N Engl J Med       Date:  1984-07-12       Impact factor: 91.245

7.  Glomerular structure in type-1 (insulin-dependent) diabetic patients with normo- and microalbuminuria.

Authors:  J D Walker; C F Close; S L Jones; M Rafftery; H Keen; G Viberti; R Osterby
Journal:  Kidney Int       Date:  1992-04       Impact factor: 10.612

8.  Effects of duration and age at onset of type 1 diabetes on preclinical manifestations of nephropathy.

Authors:  Keith N Drummond; Michael S Kramer; Samy Suissa; Claire Lévy-Marchal; Sophie Dell'Aniello; Alan Sinaiko; Michael Mauer
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

9.  Glomerular filtration surface in type I diabetes mellitus.

Authors:  E N Ellis; M W Steffes; F C Goetz; D E Sutherland; S M Mauer
Journal:  Kidney Int       Date:  1986-04       Impact factor: 10.612

10.  Glomerular hyperfiltration increases the risk of developing microalbuminuria in diabetic children.

Authors:  F Chiarelli; A Verrotti; G Morgese
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

View more
  7 in total

1.  Mastering a mediator: blockade of CCN-2 shows early promise in human diabetic kidney disease.

Authors:  Stephen M Twigg
Journal:  J Cell Commun Signal       Date:  2010-10-19       Impact factor: 5.782

Review 2.  Mitochondrial dysfunction and mitophagy: the beginning and end to diabetic nephropathy?

Authors:  G C Higgins; M T Coughlan
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

3.  Diagnosis and Prediction of CKD Progression by Assessment of Urinary Peptides.

Authors:  Joost P Schanstra; Petra Zürbig; Alaa Alkhalaf; Angel Argiles; Stephan J L Bakker; Joachim Beige; Henk J G Bilo; Christos Chatzikyrkou; Mohammed Dakna; Jesse Dawson; Christian Delles; Hermann Haller; Marion Haubitz; Holger Husi; Joachim Jankowski; George Jerums; Nanne Kleefstra; Tatiana Kuznetsova; David M Maahs; Jan Menne; William Mullen; Alberto Ortiz; Frederik Persson; Peter Rossing; Piero Ruggenenti; Ivan Rychlik; Andreas L Serra; Justyna Siwy; Janet Snell-Bergeon; Goce Spasovski; Jan A Staessen; Antonia Vlahou; Harald Mischak; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2015-01-14       Impact factor: 10.121

4.  Urinary proteomics for early diagnosis in diabetic nephropathy.

Authors:  Petra Zürbig; George Jerums; Peter Hovind; Richard J Macisaac; Harald Mischak; Stine E Nielsen; Sianna Panagiotopoulos; Frederik Persson; Peter Rossing
Journal:  Diabetes       Date:  2012-08-07       Impact factor: 9.461

5.  Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy.

Authors:  Ahmed A Elmarakby; Rafik Abdelsayed; Jun Yao Liu; Mahmood S Mozaffari
Journal:  EPMA J       Date:  2010-03-13       Impact factor: 6.543

6.  Combining genetic association study designs: a GWAS case study.

Authors:  Janice L Estus; David W Fardo
Journal:  Front Genet       Date:  2013-09-27       Impact factor: 4.772

Review 7.  Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy with Induced Pluripotent Stem Cells.

Authors:  Felipe Arroyave; Diana Montaño; Fernando Lizcano
Journal:  Int J Mol Sci       Date:  2020-11-18       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.